We built the membership we wished existed.

Tony Medrano is CEO and co-founder of LongevityPlan.AI, a platform that integrates performance and health data from athletes and leverages proprietary digital twin technology, wearable data, and biomarker data to deliver personalized performance optimization and longevity recommendations to athletes, coaches, organizations, businesses, government, and the military. In addition to being a 3x technology company CEO with 2 successful exits, Tony has also finished 3 Full Ironman Triathlons (140.6 mi) since 2019. He has degrees from Harvard University, Columbia University, and a JD/MBA from Stanford University. Tony has been involved with AI and molecular diagnostic start-ups for 10 years, and also worked with the US Olympic Team, NBA, NFL, MLB, Iditarod, FBI, NASA, U.S. Department of Health and Human Services (HHS), Google, Microsoft, Netflix, Bridgewater Associates, ConocoPhillips, British Petroleum, Jenny Craig, Inc. and Chevron to provide technology, AI and/or molecular diagnostics solutions to their employees.

One of Tony's prior companies provided Conversational AI to health, fitness, and wellness companies; another delivered access to digital libraries of British Petroleum for oil discovery; and his first was a mobile app platform funded by Softbank, which resulted in a case study published by Stanford University Press, and was taught in multiple MBA programs for a decade. Tony loves to teach and mentor; he earned public school teaching credentials in NY and MA and taught inner city high school students to give back to an underprivileged community in Harlem. He also lectured on entrepreneurship and venture capital to second-year MBA students at Stanford Business School for five years. He co-authored one of the first issued patents for mobile applications. Tony also served as a US Navy Officer commanding an emergency response team on a USN Destroyer. Tony's military-to-CEO career has recently been chosen to air on an episode of “Operation CEO,” a documentary by InsideSuccess.TV airing on AppleTV, Prime Video & Amazon MGM Studios, YouTubeTV, and other major platforms worldwide in Q1 2026.

Dr. Karim Godamunné is the Chief Medical Officer at LongevityPlan.AI and a physician executive with more than two decades of experience driving clinical transformation, operational excellence, and technology-enabled care delivery. Prior to joining LongevityPlan.AI, he served as Chief Medical Officer at Wellstar North Fulton Hospital, where he led major initiatives in quality, safety, and patient throughput that contributed to the organization receiving the prestigious Oglethorpe Award for performance excellence. He has built and led high-impact programs across trauma, stroke, perioperative surgical care, palliative medicine, obstetrics, and graduate medical education.

A pioneer in virtual care, Dr. Godamunné launched one of Atlanta's earliest telestroke programs, achieving Joint Commission Primary Stroke Center Certification within its first year. He is coauthor of the nationally recognized Malnutrition Quality Improvement Initiative (MQII), now adopted by more than 700 hospitals nationwide, and led enterprise-wide stewardship efforts that reduced opioid utilization by 25% across an 11-hospital system.

During the COVID-19 pandemic, his leadership was marked by rapid, data-driven innovation — deploying surge-forecasting models, championing in-house diagnostic test development, operationalizing alternative care delivery models, and forging community partnerships to strengthen response efforts.

Dr. Godamunné earned his MBA from Stanford University and his MD from Rutgers New Jersey Medical School, where he was elected to Alpha Omega Alpha. He completed his Internal Medicine residency at Columbia University Medical Center and is board-certified in Internal Medicine. He is a Fellow of the American College of Healthcare Executives, a Certified Physician Executive, and a Senior Fellow in Hospital Medicine.

Karim is also a 3rd degree black belt in karate.

Hannah is a frontend design engineer with a background in data analytics and a Master's in Information and Data Science from UC Berkeley. She brings experience translating complex data into intuitive, human-centered visualizations across enterprise organizations.

At LongevityPlan.AI, Hannah leads the design and development of user-facing data experiences, building the interfaces that make personalized longevity insights accessible and actionable. She focuses on using AI and thoughtful design to help people understand and optimize their health.

Molly Bunting is a senior at Boston University, majoring in Biology with a minor in Business Administration and Management. Her experience spans biomedical research, clinical medicine, hospital laboratory operations, and international health systems. She has conducted research at NYU Langone Health and currently performs undergraduate research at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), one of only thirteen BSL-4 facilities in the United States. She has also held clinical and laboratory roles at Tallaght University Hospital in Dublin. After she graduates this Spring 2026, Molly will begin the University of Pennsylvania's Pre-Health Post-Baccalaureate Program that summer, continuing her preparation for a career in medicine and biomedical research.

Dr. Eric Rightmire is a dual Board Certified Orthopedic Surgeon specializing in sports medicine. He earned his BA from Harvard University and his MD from SUNY. He completed his residency and internship at Harvard.

Dr. Rightmire has served as an orthopedic surgeon to celebrity athletes and is a member of the prestigious Quigley Society. His expertise in sports injuries and arthritis treatment makes him a valuable advisor to the LongevityPlan.AI team.

Dr. Crystal Broussard is a board-certified physician serving as Chief Medical Officer of LongevityPlan.AI's peptide telehealth partner. She leads medical oversight for the peptide program, including clinical protocols, prescribing standards, and patient safety across every state we serve.

Her practice emphasizes evidence-based, individualized care — combining a careful intake process, lab work where appropriate, and ongoing follow-up to ensure peptide therapies are used responsibly and effectively. All prescriptions are dispensed through 503A compounding pharmacies that meet rigorous US quality standards.

At LongevityPlan.AI, Dr. Broussard partners closely with our medical and product teams to ensure that peptide recommendations integrated into the Digital Twin are clinically sound, appropriately personalized, and aligned with the latest peer-reviewed research.

Lisa Castleton is a seasoned executive with over 15 years of leadership experience in life sciences and healthcare technology. She most recently served as Vice President and Associate General Counsel at ImmunityBio, where she partnered with C-suite leadership to launch the company's first global commercial product and built scalable infrastructure to support rapid clinical and commercial expansion.

Prior to ImmunityBio, she held senior roles at Spectrum Pharmaceuticals, Abbott, and Edwards Lifesciences, guiding organizations from clinical-stage development through FDA approval and commercialization. Her expertise includes navigating complex regulatory environments, clinical trial operations, and strategic partnerships.

Lisa earned her J.D. from Yale Law School and graduated magna cum laude from Harvard University. She is passionate about the intersection of technology and human health and advises LongevityPlan.AI on regulatory pathways and strategic growth as the company explores potential clinical applications for its technology.

Dr. Chaitanya Gharpure brings over 15 years of deep engineering leadership at Google, where he led large engineering teams and generated 30+ patents building and scaling platforms across machine learning, robotics, and consumer products. His career spans assistive robotics research, large-scale systems, and applied AI, giving LongevityPlan.AI a unique technical perspective on the agentic AI architectures that power our Digital Twin.

He is CTO of Wellpro.ai, an AI-native, vertically integrated healthcare operating system serving primary care, longevity, functional medicine, and concierge medicine practices. Previously, he was Co-founder and CTO at Sully.ai, where he helped build AI agents for healthcare through seed and Series A. He also built Fittrlfe.ai, a holistic health and wellness platform. This track record sits directly at the intersection of AI, healthcare workflows, and patient experience — the same domain LongevityPlan.AI is transforming.

Dr. Gharpure advises our team on AI infrastructure, model selection, data pipelines, and the practical realities of building HIPAA-aligned healthcare software that physicians and patients actually trust and use every day.

Arash Mirbagheri is a Principal Systems Engineer with a strong record of innovation and leadership in wireless communications, data science, and applied machine learning. With over 20 years of experience, Arash has played a key role in the design, development, and commercialization of cutting-edge products, including industrial Digital Twins, helping shape industry standards and advance next-generation solutions. He holds a Ph.D. in Electrical Engineering from the University of Waterloo, is the inventor of more than 300 patents, and has authored multiple peer-reviewed publications.

Beyond his professional achievements, Arash is passionate about endurance sports. For over a decade, he has trained with Breakaway Training under coach Felipe Loureiro, completing numerous marathons, Ironman 70.3 triathlons, and endurance cycling events. Combining his love for athletic performance with expertise in AI/ML engineering, Arash contributes as a technical advisor to LongevityPlan.AI, supporting initiatives that promote health, longevity, and athletic performance through technology.

Dr. Swathi Varanasi-Diaz, known professionally as Dr. Swathi, is an award-winning pharmacist and medical affairs leader passionate about the intersection of evidence-based integrative health, longevity, and healthcare innovation.

She is the Managing Director of Varanasi & Company, a consulting firm providing medical affairs and strategic consulting for consumer health brands including supplements, health foods, healthtech platforms, aesthetic startups, and media ventures. Through fractional executive roles and high-impact consulting projects, Dr. Swathi helps brands generate clinical evidence, craft medically-driven messaging, uphold regulatory standards, educate their consumers, and build healthcare provider engagement channels.

With experience across clinical care, pharma, biotech, CPG, academia, and clinical trials, Dr. Swathi is recognized as a trusted expert in navigating non-FDA regulated product landscapes and competitive consumer health markets with scientific rigor. She has also created postdoctoral residency programs, fellowships, and mentorship initiatives to train the next generation of healthcare professionals in non-traditional career paths.

Dr. Swathi is a sought-after speaker and recurring medical expert on TV (CBS, NBC, ABC) and radio. She has been published in peer-reviewed journals and featured in Well+Good, mindbodygreen, Forbes Health, Yahoo, and Thrive Global. In 2023, she was named one of the 50 Most Influential Leaders in Pharmacy.

She received her Doctor of Pharmacy (PharmD) from the Medical University of South Carolina and her Bachelor of Arts from Carleton College. She is the first pharmacist in the U.S. to complete formal postdoctoral residency training in integrative medicine and preventive health, in addition to a postdoctoral fellowship in Medical Affairs and certification in clinical nutrition from Cornell University.

Dr. Tandhoni Rao is a recognized expert in DEXA imaging and body-composition science, with deep experience interpreting bone density, lean mass, fat distribution, and visceral adipose tissue measurements in the context of long-term health.

He helps clinicians, coaches, and individuals translate raw DEXA results into clear action plans — connecting the dots between scan data, training load, nutrition, and the biomarkers that drive healthspan and performance over decades.

At LongevityPlan.AI, Dr. Rao advises on the integration of DEXA-derived metrics into our Digital Twin, ensuring that body-composition data is interpreted with rigor and used to personalize longevity, performance, and wellness strategies for every member.

Dr. Kevin Kozak is a board-certified radiation oncologist and physician-scientist with two decades of experience treating cancer patients across leading academic centers and community practices. He holds an A.B. in Chemistry from Harvard University (magna cum laude with highest honors), a Ph.D. in Biochemistry from Vanderbilt University School of Medicine, and an M.D. from Vanderbilt, where he received the Founder's Medal as first in his class. He completed residency training at Brockton Hospital/Boston University Medical Center and the Harvard Radiation Oncology Program, followed by a Holman Fellowship at the Edwin L. Steele Laboratory at Massachusetts General Hospital under Professor Rakesh Jain.

Kevin's career spans academic medicine, biotech leadership, and patient care. He has served as Assistant Professor at the University of Wisconsin and Chief of Radiation Oncology at Mercy Regional Cancer Center, plus Chief Medical Officer at Novelos Therapeutics and Cellectar Biosciences, and Co-Founder, Director, and CMO at Co-D Therapeutics. He continues to practice as a Radiation Oncologist at Mercy Regional Cancer Center and SSM Health System, while serving as Director of Breathe (Cancer Advocacy) and Scientific Advisor at Alkyon Therapeutics.

He is a former U.S. Navy Intelligence Officer (1992–1996), an Assistant Professor/Fellow in the Department of Medical Physics at the University of Wisconsin, and was named one of Madison Magazine's Top Doctors in Radiation Oncology. He is widely published in peer-reviewed journals across radiation oncology, biochemistry, and translational cancer research.

Dr. Todd Harple is an anthropologist and innovation ecosystem builder whose career bridges human behavior research, emerging technology, and elite sport. He has spent over two decades working at the intersection of AI, wearables, and physical performance — not as a distant advisor, but as someone who builds the actual thing. His expertise spans qualitative research, design thinking, digital twins, and the human-centered strategies that make technology stick in complex organizations.

He has worked alongside Olympic committees, physicians, and technology teams to design innovation systems that scale from individual athletes to the Games themselves — including leading the deployment of AthleteGPT, the first AI assistant built specifically for Olympic athletes, at Paris 2024.

At LongevityPlan.AI, Dr. Harple serves on the Scientific Advisory Board, contributing expertise in wearables, AI, sport, digital twins, and longevity — and how the Digital Twin can model the adaptation curves that determine long-term healthspan and performance.